Successful regeneration depends on balancing two requirements: removing bound analytes and retaining the chip’s plasmonic nanostructure and capture chemistry. A treatment that leaves affinity complexes attached limits reuse, whereas an overly disruptive treatment may compromise later measurements. This balance determines whether the same surface can support subsequent biosensing cycles and help reduce assay variability.
Regeneration must release the antigen, antibody, or other target captured during a measurement so that the sensing surface becomes available for another sample. The treatment therefore acts on the affinity interaction rather than simply removing material from the chip. In immunology and infection studies, this enables repeated detection using the same capture surface.
Chemical and physical treatments represent different ways to disrupt analyte binding, but the overview does not identify one universally preferred approach. The relevant distinction is how effectively each treatment breaks the antigen–antibody or other affinity interaction while preserving the nanostructure and capture chemistry. Selection therefore depends on maintaining the surface properties needed for later measurements.
After analytes bind to the nanostructured sensing surface, the chip receives a carefully selected chemical or physical treatment intended to disrupt those interactions. The surface must then remain suitable for another measurement, with its plasmonic structure and capture chemistry preserved. Repeating this cycle allows one chip to support sequential biosensing measurements rather than a single use.
Researchers would use regeneration when repeated measurements of antibodies, antigens, or pathogen-associated biomarkers are needed from small samples. Reusing the sensing surface can reduce reagent consumption and cost while supporting label-free, real-time biosensing. This is especially relevant when multiple measurements are required and minimizing assay-to-assay variation improves the practicality of the study.
The main practical outcomes are repeated usability, reduced assay variability, lower reagent use, and lower cost. Effective treatment can also extend chip lifetime, making label-free, real-time detection more practical. These benefits depend on restoring the surface for subsequent measurements without damaging the plasmonic nanostructure or the capture chemistry required for analyte recognition.